Search | TVST | ARVO Journals

Showing 1 – 20 of 217

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina September 2024

Establishing Clinical Trial Endpoints in Selecting Patients for RPGR Retinal Gene Therapy

PDF

Evita Evangelia Christou; Amandeep S. Josan; Jasmina Cehajic-Kapetanovic; Robert E. MacLaren
TAGS: gene therapy, retinitis pigmentosa, surrogate endpoints
Trans. Vis. Sci. Tech.. 2024; 13(9):18. https://doi.org/10.1167/tvst.13.9.18

Review June 2024

Robot-Assisted Eye Surgery: A Systematic Review of Effectiveness, Safety, and Practicality in Clinical Settings

PDF

Arun J. Thirunavukarasu; Monica L. Hu; William P. Foster; Kanmin Xue; Jasmina Cehajic-Kapetanovic; Robert E. MacLaren
TAGS: ophthalmologic surgical procedures, safety, surgical procedures, operative, systematic reviews, surgeons, robotic surgery, screening, healthcare quality assessment, laparotomy
Trans. Vis. Sci. Tech.. 2024; 13(6):20. https://doi.org/10.1167/tvst.13.6.20

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Effectiveness, safety, and practicality of robotic systems in eye surgery: A systematic review

Arun James Thirunavukarasu; Monica L. Hu; William P. Foster; Kanmin Xue; Jasmina Cehajic Kapetanovic; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):888.

ARVO Annual Meeting Abstract June 2024

A novel gene deletion in the 10q23.1 locus suggests a potential role of LRIT1 and/or LRIT2 in human retinal degeneration

Dana Zhupan; Rupal Morjaria; Robert E MacLaren; Imran H Yusuf

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4693.

ARVO Annual Meeting Abstract June 2024

Meta-analysis of Gene Therapy Associated Uveitis (GTAU)

Thomas Buckley; Robert E MacLaren; Jasmina Cehajic Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5312.

ARVO Annual Meeting Abstract June 2024

Early onset cone photoreceptor degeneration as a risk factor for high myopia in RPGR-retinal dystrophy

Shabnam Raji; Laura J Taylor; Amandeep Singh Josan; Robert E MacLaren; Jasmina Cehajic-Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1187.

ARVO Annual Meeting Abstract June 2024

CDHR1- associated retinal degeneration: clinical phenotypes, natural history and molecular genetics from 135 cases

Imran H Yusuf; Richard Caswell; Stephen H Tsang; Carmen Ayuso; Dror Sharon; Juliana M F Sallum; Carel C B Hoyng; Petra Liskova; Ajoy Vincent; Madhavan Jagadeesan; Bart Peter Leroy; Jose Millán; Smaragda Kamakari; Andrew Webster; Robert E MacLaren; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2132.

ARVO Annual Meeting Abstract June 2024

Ranked importance of functional measures in choroideremia

Amandeep Singh Josan; Laura J Taylor; Jasmina Cehajic-Kapetanovic; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1484.

ARVO Annual Meeting Abstract June 2024

Slowly degenerating retina of Rpgr- deficient mouse remain immunologically quiescent

Molly John; Cristina Martinez-Fernandez Dela Camara; Federica Staurenghi; M Dominik Fischer; Kanmin Xue; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5051.

ARVO Annual Meeting Abstract June 2024

Phenotypic Heterogeneity in Families Carrying Identical Genetic Variants in Choroideremia Patients

Fang Helen Mi; Imran H Yusuf; Robert E MacLaren; Jasmina Cehajic-Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5296.

ARVO Annual Meeting Abstract June 2024

Validating human-derived organoids as a suitable model for testing optogenetic therapies

Hoda Shamsnajafabadi; Michelle E McClements; Robert E MacLaren; Jasmina Cehajic-Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1549.

ARVO Annual Meeting Abstract June 2024

Combined agonism of immune checkpoint receptors, PD-1 and TIGIT, suppresses development of experimental autoimmune uveitis

Joel Quinn; Ahmed Salman; Christopher Paluch; Luke Cox; Jasmina Cehajic Kapetanovic; Simon J Davis; Richard J Cornall; Robert E MacLaren; Kanmin Xue

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2988.

ARVO Annual Meeting Abstract June 2024

Ligand mediated degradation of a prime editor in vivo

Lauren Major; Michelle E McClements; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2221.

ARVO Annual Meeting Abstract June 2024

CRISPR base editing of the human apolipoprotein E ( APOE ) risk variant for age-related macular degeneration

Monica L Hu; Joel Quinn; Robert E MacLaren; Kanmin Xue

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3789.

ARVO Annual Meeting Abstract June 2024

Correlation of outer retinal structure with visual function in X-linked retinitis pigmentosa caused by RPGR gene

Evita Evangelia Christou; Amandeep Singh Josan; Jasmina Cehajic-Kapetanovic; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3094.

ARVO Annual Meeting Abstract June 2024

Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration

Grace A Borchert; Morag Shanks; Jennifer Whitfield; Penny Clouston; Shabnam Raji; Sian Sperring; Kanmin Xue; Samantha R De Silva; Susan M Downes; Robert E MacLaren; Jasmina Cehajic Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4687.

ARVO Annual Meeting Abstract June 2024

Comparison of treatment strategies for AMD-related submacular haemorrhages

Jed Golebka; Helen Mi Fang; Guy Mole; Aman Josan; Sher Aslam; Robert E MacLaren; Jasmina Cehajic Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4393.

ARVO Annual Meeting Abstract June 2024

Gene therapy for age-related macular degeneration

Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4338a.

ARVO Annual Meeting Abstract June 2024

Testing mirtron vector efficacy in wild-type retinal organoids

Sylvia Franklin; Federica Staurenghi; Michelle E McClements; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5348.

ARVO Annual Meeting Abstract June 2024

Evaluation of mirtron silencing and rhodopsin restoration in a human rhodopsin P23H knock-in mouse model

Qingyun Zheng; Maria Kaukonen; Imran H Yusuf; Federica Staurenghi; Michelle E McClements; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5344.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Establishing Clinical Trial Endpoints in Selecting Patients for RPGR Retinal Gene Therapy

Robot-Assisted Eye Surgery: A Systematic Review of Effectiveness, Safety, and Practicality in Clinical Settings

Effectiveness, safety, and practicality of robotic systems in eye surgery: A systematic review

A novel gene deletion in the 10q23.1 locus suggests a potential role of LRIT1 and/or LRIT2 in human retinal degeneration

Meta-analysis of Gene Therapy Associated Uveitis (GTAU)

Early onset cone photoreceptor degeneration as a risk factor for high myopia in RPGR-retinal dystrophy

CDHR1- associated retinal degeneration: clinical phenotypes, natural history and molecular genetics from 135 cases

Ranked importance of functional measures in choroideremia

Slowly degenerating retina of Rpgr- deficient mouse remain immunologically quiescent

Phenotypic Heterogeneity in Families Carrying Identical Genetic Variants in Choroideremia Patients

Validating human-derived organoids as a suitable model for testing optogenetic therapies

Combined agonism of immune checkpoint receptors, PD-1 and TIGIT, suppresses development of experimental autoimmune uveitis

Ligand mediated degradation of a prime editor in vivo

CRISPR base editing of the human apolipoprotein E ( APOE ) risk variant for age-related macular degeneration

Correlation of outer retinal structure with visual function in X-linked retinitis pigmentosa caused by RPGR gene

Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration

Comparison of treatment strategies for AMD-related submacular haemorrhages

Gene therapy for age-related macular degeneration

Testing mirtron vector efficacy in wild-type retinal organoids

Evaluation of mirtron silencing and rhodopsin restoration in a human rhodopsin P23H knock-in mouse model

To View More...

You must be signed into an individual account to use this feature.